CompoAtlas

PiantoBiotic Métabolisme Hormonal

Food supplement declared in France, decision dated 21 March 2025

PiantoBiotic Métabolisme Hormonal (Pianto) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 1 rule of use applies to its ingredients (limits and warnings).

Brand
Pianto
Food business operator placing the product on the market
Pianto Healthcare Sàrl
Status
Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
Form
Sirop
Daily dose
10 ml
Directions for use
10 ml par jour (2 c. à c.).
Intended populations
Homme, Femme
Not recommended for (according to the manufacturer)
Femmes allaitantes, Antécédent de cancer du sein, Femmes enceintes
Objectives stated by the manufacturer (these are not authorised claims)
Ménopause

Declaration 146053, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Trifolium pratense L.Parties aériennesExtrait sec hydroalcoolique438 mg
Angelica sinensis (Oliv.) DielsRacineExtrait sec aqueux133 mg
Salvia officinalis L.FeuilleExtrait sec aqueux83 mg

Substances

NamePer day
fructose5,678 mg
arabinogalactanes52 mg

Other active ingredients

NamePer day
Pollennot declared
mielnot declared
Levure de bière inactivéenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Chlorhydrate de thiamineVitamine B1 (thiamine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
RiboflavineVitamine B2 (riboflavine)pas de limite (données insuffisantes)dose annulée par le Conseil d'État en 2011
Chlorhydrate de pyridoxineVitamine B612 mg2 mg
Sulfate de zincZinc25 mg15 mg

Additives

E307, E300

Other ingredients

Chamaemelum nobile (L.) All., Zingiber officinale Roscoe, Lavandula angustifolia Mill., Abies sibirica Ledeb., Rosmarinus officinalis L., Syzygium aromaticum (L.) Merr. & L.M.Perry, Daucus carota L., Laurus nobilis L., Artemisia dracunculus L., Thymus vulgaris L., Origanum vulgare L., Citrus sinensis (L.) Osbeck, Citrus paradisi Macfad., Ocimum basilicum L., Foeniculum vulgare Mill., Citrus reticulata Blanco, Eucalyptus globulus Labill., Mentha x piperita L., Carum carvi L., Piper nigrum L., Citrus limon (L.) Burm. f., Satureja montana L., Cupressus sempervirens L., Jus de framboise, Jus de myrtille, Jus de cassis

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Label warnings

Ne pas dépasser la dose journalière recommandée. Les compléments alimentaires ne se substituent pas à une alimentation variée, équilibrée et à un mode de vie sain. Tenir hors de portée des jeunes enfants. Déconseillé chez la femme enceinte, allaitante ou ayant des antécédents personnels ou familiaux de cancer du sein et en cas d’allergie aux produits de la ruche.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Angelica sinensis (Oliv.) Diels
    Read the warning, when it applies and the studies cited

    DONG QUAI - ANGELICA SINENSIS

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding (NS 2021).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you are taking any medications including blood thinners, birth control pills or hormone therapy (NS 2021; Brinker 2010; WHO 2002).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have serious or major conditions, any type of acute infection, deficiency or excess (HC 2022).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid exposure to the sun (NS 2021; Thorne 2004).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Do not use if you are pregnant (NS 2021; WHO 2002).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have diarrhea, hemorrhagic diseases or heavy periods (NS 2021, Bensky et al. 2004; Chen and Chen 2004; WHO 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen, or if new symptoms develop such as breast pain or any changes in menstrual cycles (Brinker 2010; Schumacher et al. 2007; Thorne 2004; Russell et al. 2002).

    4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 29 May 2026

  • Salvia officinalis L.
    Read the warning, when it applies and the studies cited

    SAGE - SALVIA OFFICINALIS - Buccal

    Cautions and warnings

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen or last (for) more than 7 days.

    Health Canada monograph dated 28 March 2025

    SAGE -SALVIA OFFICINALIS Oral

    Cautions and warnings

    Condition of application: Carminative, Diaphoretic, Antihidrotic, Antigalactagogue.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Contraindications

    Condition of application: All products.

    Do not use if you are pregnant or breastfeeding (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Do not use if you have a seizure disorder such as epilepsy (Gardner and McGuffin 2013; Bradley 2006; Mills and Bone 2005).

    3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 10 January 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Brand : Pianto

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line